Clinical Trials on Carcinomatosis, Peritoneal

Total 1824 results

Michael Bau Mortensen

Recruiting

Adjuvant Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) in Resected High Risk Colon Cancer Patients

Colo-rectal Cancer | Peritoneal Carcinomatosis | Peritoneal Metastases | Peritoneum Cancer

Denmark
Institut du Cancer de Montpellier - Val d'Aurelle

Recruiting

Impact of Cardiac Coherence on Anxiety in Patients Operated on for a Peritoneal Carcinosis (COCOON)

Pseudomyxoma Peritonei | Peritoneal Carcinomatosis | Mesothelioma Peritoneum

France
Ziekenhuis Oost-Limburg

Completed

Thrombin Generation and Platelet Activation in CRS/HIPEC

Pseudomyxoma Peritonei | Peritoneal Carcinomatosis | Mesothelioma; Peritoneum
Association Francaise de Chirurgie

Completed

Effect of the PIPAC on the Survival Rate of Patients With Peritoneal Carcinomatosis of Gastric Origin

Carcinomatosis, Peritoneal

France
Hasselt University
Ziekenhuis Oost-Limburg

Unknown

Concentration- Versus Body Surface Area-based HIPEC in Colorectal Peritoneal Carcinomatosis' Treatment (COBOX)

Colorectal Peritoneal Carcinomatosis

Belgium
Hospices Civils de Lyon

Unknown

Study Comparing the Role of the Laparoscopy Surgical Staging in the Peritoneal Carcinomatosis to Laparotomic Approach (COELIOCHIP)

Colorectal Peritoneal Carcinomatosis

France
University of California, Irvine

Recruiting

Patient Derived Vascularized MicroTumor Model of Gastrointestinal Peritoneal Carcinomatosis

Peritoneal Carcinomatosis | Gastrointestinal Peritoneal Carcinomatosis

United States
Gustave Roussy, Cancer Campus, Grand Paris

Terminated

Treatment of Gastric Peritoneal Carcinomatosis by Association of Complete Surgical Resection of the Lesions and Intraperitoneal Immunotherapy Using Catumaxomab (IIPOP)

Patients With Gastric Peritoneal Carcinomatosis

France
Hospices Civils de Lyon

Completed

Clinical and Biological Digestive Peritoneal Carcinomatosis Data Base From the French National Network of Peritoneal Surface Malignancies (BIG-RENAPE)

Digestive Peritoneal Carcinomatosis

France
Uppsala University

Completed

Cytoreduction and Intraperitoneal Chemotherapy Versus Systemic Chemotherapy in Colorectal Peritoneal Carcinomatosis

Colorectal Peritoneal Carcinomatosis

Sweden
Michael Bau Mortensen

Completed

Treatment of Peritoneal Carcinomatosis With Pressurized IntraPeritoneal Aerosol Chemotherapy - (PIPAC-OPC2)

Quality of Life | Peritoneal Neoplasms | Chemotherapy Effect | Chemotherapeutic Toxicity | Peritoneal Metastases | Peritoneum; Carcinomatosis | Histologic Progression

Denmark
AIO-Studien-gGmbH
Neovii Biotech

Completed

Catumaxomab for Treatment of Peritoneal Carcinomatosis in Patients With Gastric Adenocarcinomas (CatuNeo)

Gastric Adenocarcinoma With Peritoneal Carcinomatosis | Siewert Type II Adenocarcinoma of Esophagogastric Junction With Peritoneal Carcinomatosis | Siewert Type III Adenocarcinoma of Esophagogastric Junction With Peritoneal Carcinomatosis

Germany
M.D. Anderson Cancer Center

Completed

Oxaliplatin and Paclitaxel Plus Bevacizumab in Advanced Peritoneal Carcinomatosis

Peritoneal Cancer

United States
Carlos Chan
Institute of Quantitative Systems Pharmacology (IQSP)

Recruiting

Intraperitoneal Paclitaxel-loaded TPM for Treatment of Peritoneal Carcinomatosis

Peritoneal Carcinomatosis

United States
Maimónides Biomedical Research Institute of Córdoba

Completed

Study of Safety and Efficiency of the Use of Neutral Argon Plasma in Cyto-reduction of Miliary Implants in the Peritoneal Surface. (Plasmajet)

Peritoneal Carcinomatosis

Spain
University of Leipzig

Unknown

Register Study of Patients With Peritoneal Carcinomatosis Treated With PIPAC (Pressurized Intra-peritoneal Aerosol-Chemotherapy) (PIPAC_01)

Peritoneal Carcinomatosis

Germany
Sleiman Marwan-Julien

Not yet recruiting

Second Line Oxaliplatin Based Chemotherapy Alone Versus Oxaliplatin Based PIPAC and Chemotherapy in Colorectal Peritoneal Carcinomatosis : A Phase II Randomize Mutli-centric Study (OPAC)

Peritoneal Carcinomatosis
University of Regensburg
Krankenhaus Barmherzige Brüder, Regensburg

Recruiting

Longitudinal Study of CRS/HIPEC for Peritoneal Carcinomatoses (CRS/HIPEC)

Peritoneal Carcinomatosis

Germany
Mayo Clinic

Completed

Intravital Microscopy (IVM) in Patients With Peritoneal Carcinomatosis (PC)

Peritoneal Carcinomatosis

United States
University Ghent
Belgian Federation Against Cancer

Completed

Role of the Peritoneal Microenvironment in the Pathogenesis and Spread of Colorectal Carcinomatosis (MMT)

Peritoneal Carcinomatosis

Belgium
Centre de l'arthrose, Paris

Completed

Link of Interest and Training Model

Peritoneal Carcinomatosis

France
Kantonsspital Winterthur KSW

Unknown

Prospective Intraperitoneal Chemotherapy in Carcinomatosis Cohort Study

Peritoneal Carcinomatosis

Switzerland
Uppsala University

Completed

Single-photon Emission Computed Tomography (SPECT) to Predict Peritoneal Chemotherapy

Peritoneal Carcinomatosis

Sweden
Washington University School of Medicine

Active, not recruiting

Biweekly Intraperitoneal Oxaliplatin With Systemic Capecitabine and Bevacizumab for Patients With Peritoneal Carcinomatosis From Appendiceal or Colorectal Cancer

Carcinoma

United States
Institut du Cancer de Montpellier - Val d'Aurelle

Completed

Study in Patients With Peritoneal Carcinomatosis From CEA Overexpressing Digestive Cancer (FLUOCAR-1)

Peritoneal Carcinomatosis

France
Michael Bau Mortensen

Completed

Treating Peritoneal Carcinomatosis With PIPAC

Peritoneal Carcinomatosis

Denmark
Institut für Klinische Krebsforschung IKF GmbH...

Recruiting

Feasibility and Safety of IMP321 (Eftilagimod Alpha) for Advanced Stage Solid Tumors

Solid Tumors | Peritoneal Carcinomatosis

Germany
National University Hospital, Singapore

Recruiting

Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) With Oxaliplatin In Patients With Peritoneal Carcinomatosis (PIPAC)

Peritoneal Carcinomatosis

Belgium, Singapore
National University Hospital, Singapore

Recruiting

Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) and Electrostatic PIPAC (ePIPAC) With Paclitaxel In Patients With Peritoneal Carcinomatosis

Peritoneal Carcinomatosis

Singapore
Institut du Cancer de Montpellier - Val d'Aurelle

Completed

Assessing Safety of NIPOX in Peritoneal Carcinomatosis of CRC (NIPOX)

Colorectal Cancer

France
Fondazione del Piemonte per l'Oncologia

Completed

Study of Efficacy and Safety of Laparoscopic Intra-abdominal Chemotherapy (PIPAC) Performed in Patients With Peritoneal Carcinomatosis From Colorectal, Ovarian, Gastric Cancer and Primary Peritoneal Tumors (PI-CaP)

Peritoneal Carcinomatosis

Italy
Sichuan Clover Biopharmaceuticals, Inc.

Terminated

A Phase I Study Evaluating SCB-313 for the Treatment of Subjects With Peritoneal Carcinomatosis

Peritoneal Carcinomatosis

China
Uppsala University Hospital

Recruiting

The Impact of Gut Microbiota in Anastomoses Insufficiency After Resection and Direct Anastomosis for Colorectal Cancer.

Colorectal Cancer, Peritoneal Carcinomatosis, Anastomosis Insufficiency

Sweden
Institut de Cancérologie de Lorraine

Recruiting

Bonds Between Circulating Tumoral ADN (ctDNA) and the Development of Peritoneal Carcinomatosis for Patients Under PIPAC (PIPADN)

Peritoneal Carcinomatosis

France
OncoNano Medicine, Inc.

Completed

A Study to Evaluate Pegsitacianine, an Intraoperative Fluorescence Imaging Agent for the Detection of Peritoneal Metastases in Patients Undergoing Cytoreductive Surgery

Peritoneal Carcinomatosis

United States
Postgraduate Institute of Medical Education and...

Terminated

Comparison of "Roll-over' Technique With Standard Abdominal Paracentesis in Suspected Peritoneal Carcinomatosis (ROLLON)

Ascites | Peritoneal Carcinomatosis | Peritoneum Neoplasm | Tuberculous Peritonitis

India
University of California, San Diego

Terminated

Postoperative Chemotherapy in High-Grade Appendiceal Adenocarcinoma With Peritoneal Carcinomatosis

Cancer

United States
University Hospital Tuebingen

Unknown

Pilot Study on Intra-abdominal Photodynamic Diagnosis in Peritoneal Carcinosis (Hypericin-PDT)

Peritoneal Carcinomatosis

Germany
Gustave Roussy, Cancer Campus, Grand Paris

Terminated

Pasireotide to Reduce Clinically Relevant Digestive Leakage After Complete Cytoreductive Surgery (CRS) Plus Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC) for Peritoneal Carcinomatosis (PASIREOCHIP)

Peritoneal Carcinomatosis

France
University Hospital, Ghent
University Ghent

Completed

Cytoreduction Followed by Normothermic Versus Hyperthermic Intraperitoneal Intraoperative Chemoperfusion (HIPEC): a Study in Peritoneal Carcinomatosis

Peritoneal Carcinomatosis

Belgium
Radboud University Medical Center

Completed

Clinical Pharmacology of Platinum-based Hyperthermic Intraperitoneal Chemotherapy (GUTOX)

Peritoneal Carcinomatosis

Netherlands
Prakash Pandalai

Recruiting

Flat Dose vs. Weight-based IP Chemotherapy for CRS/HIPEC

Peritoneal Carcinomatosis

United States
Novartis Pharmaceuticals

Completed

Octreotide Compared to Placebo in Patients With Inoperable Bowel Obstruction Due to Peritoneal Carcinomatosis

Peritoneal Neoplasms | Intestinal Obstruction | Carcinomatosis

France
Odense University Hospital

Not yet recruiting

The PIPAC PET Pilot Study, OPC-7

Abdominal Cancer | Peritoneal Carcinomatosis | Peritoneal Cancer | Peritoneal Metastases
CHU de Reims

Completed

A Nomogram to Predict Major Postoperative Complications After Cytoreductive Surgery and HIPEC Based on Pre and Peroperative Criteria: Which Patient Require Intensive Monitoring?

Peritoneal Carcinomatosis

France
Hospices Civils de Lyon

Completed

Representation of the Body for Patients With Cancer (CORCAN)

Peritoneal Carcinomatosis

France
Maisonneuve-Rosemont Hospital

Completed

FloSeal in CRS and HIPEC

Peritoneal Carcinomatosis

Canada
Prof. Aviram Nissan

Not yet recruiting

Combined Neoadjuvant Systemic and PIPAC Therapy (NASPIT) for Patients With Colorectal Peritoneal Metastasis Eligible for CRS and HIPEC: A Prospective Phase II Trial

Metastatic Colorectal Cancer | Peritoneal Carcinomatosis | Colon Adenocarcinoma
Radboud University Medical Center
Dutch Cancer Society

Unknown

Multi-modality Imaging in Peritoneal Carcinomatosis of Colorectal Origin (MMIPC)

Neoplasms | Carcinoma | Colorectal Cancer | Gastrointestinal Cancer | Peritoneal Carcinomatosis

Netherlands
EGEN, Inc.

Terminated

A Study of the Safety and Biological Activity of Intraperitoneal (IP) EGEN-001 Administered Alone and in Combination With Standard Chemotherapy in Colorectal Peritoneal Carcinomatosis Patients

Colorectal Cancer

United States

3

Subscribe